{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:11:38Z","timestamp":1793232698756,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":45,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100006641","name":"UNICEF","doi-asserted-by":"publisher","award":["58514"],"award-info":[{"award-number":["58514"]}],"id":[{"id":"10.13039\/100006641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006641","name":"UNICEF","doi-asserted-by":"publisher","award":["68273"],"award-info":[{"award-number":["68273"]}],"id":[{"id":"10.13039\/100006641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.01.018","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T18:12:59Z","timestamp":1579803179000},"page":"3800-3807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Use of tetanus-diphtheria (Td) vaccine in children 4\u20137\u00a0years of age: World Health Organization consultation of experts"],"prefix":"10.1016","volume":"38","author":[{"given":"Shalini","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Scobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.018_b0005","first-page":"53","article-title":"Tetanus vaccines: WHO position paper - February 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec."},{"key":"10.1016\/j.vaccine.2020.01.018_b0010","first-page":"417","article-title":"Diphtheria vaccine: WHO position paper - August 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec."},{"key":"10.1016\/j.vaccine.2020.01.018_b0015","unstructured":"World Health Organization. WHO Recommendations for Routine Immunizations \u2013 Summary Tables, [Accessed 3 December 2019]. https:\/\/www.who.int\/immunization\/policy\/immunization_tables\/en\/."},{"key":"10.1016\/j.vaccine.2020.01.018_b0020","unstructured":"World Health Organization. Immunization, Vaccines and Biologicals: Data, Statistics and Graphics, 2019 [Accessed 3 December 2019]. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/en\/."},{"key":"10.1016\/j.vaccine.2020.01.018_b0025","unstructured":"World Health Organization. Protecting All Against Tetanus: Guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations Genvea: World Health Organization; 2019."},{"key":"10.1016\/j.vaccine.2020.01.018_b0030","unstructured":"WHO\/UNICEF Joint Communique. Replacement of TT with Td vaccine for dual protection (28 June 2018), [Accessed 3 December 2019]. https:\/\/www.who.int\/immunization\/diseases\/tetanus\/WHO_UNICEF_Joint_communique_on_TT_to_Td_Replacement_Final28June2018.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2020.01.018_b0035","unstructured":"Gavi the Vaccine Alliance. Gavi Board starts framing Alliance's approach to 2021-2025 period, [Accessed 3 December 2019]. https:\/\/www.gavi.org\/library\/news\/press-releases\/2018\/gavi-board-starts-framing-alliance-s-approach-to-2021-2025-period\/."},{"key":"10.1016\/j.vaccine.2020.01.018_b0040","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.vaccine.2017.02.056","article-title":"Off-label use of vaccines","volume":"35","author":"Neels","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0045","unstructured":"The Public Health Agency of Sweden. Evaluation of immunogenicity and effectiveness of low dose dTap-IPV vaccine used as booster in 4-8 year old children, [Accessed 3 December 2019]. https:\/\/www.folkhalsomyndigheten.se\/contentassets\/61c155f8099646ccb2d9b80dfde820c6\/evaluation-tap-ipv-vaccine-01192-2017.pdf."},{"key":"10.1016\/j.vaccine.2020.01.018_b0050","first-page":"47","article-title":"The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis","volume":"49","author":"Gabutti","year":"2008","journal-title":"J Prev Med Hyg."},{"key":"10.1016\/j.vaccine.2020.01.018_b0055","unstructured":"G\u00f6tz K, Bekerdjian-Ding I, [Paul-Ehrlich-Institut of the German Federal Ministry of Health]. Td\/DT vaccines in 4-7 year olds: Experience from Germany. Presented at: WHO Ad Hoc Consultation of Experts on the Use of Td Vaccine in Children 4-7 Years of Age Annecy, France [May 6, 2019]."},{"key":"10.1016\/j.vaccine.2020.01.018_b0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1600-0609.2008.01052.x","article-title":"Age-matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis","volume":"80","author":"Huenecke","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.vaccine.2020.01.018_b0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13104-015-1182-0","article-title":"Dendritic cells change IL-27 production pattern during childhood","volume":"8","author":"Meyer","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2020.01.018_b0070","unstructured":"World Health Organization. Immunological Basis for Immunization Series. Module 2: Diphtheria (2019 Update), (In press)"},{"key":"10.1016\/j.vaccine.2020.01.018_b0075","series-title":"Module 2: Diphtheria (Update 2009). Immunological Basis for Immunization Series","first-page":"28","author":"Scheifele","year":"2009"},{"key":"10.1016\/j.vaccine.2020.01.018_b0080","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1016\/j.vaccine.2018.04.064","article-title":"Antibody persistence and booster response 68months after vaccination at 2\u201310years of age with one dose of MenACWY-TT conjugate vaccine","volume":"36","author":"Knuf","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00431-012-1924-0","article-title":"Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2\u201310-year-old children: results of an open, randomised, controlled study","volume":"172","author":"Knuf","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2020.01.018_b0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0264-410X(01)00316-4","article-title":"Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age","volume":"20","author":"Ciofi degli Atti","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/hv.4.3.5290","article-title":"Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation","volume":"4","author":"Meyer","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.01.018_b0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00006454-200006000-00005","article-title":"Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group","volume":"19","author":"Stojanov","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.01.018_b0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0264-410X(96)00112-0","article-title":"Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance","volume":"15","author":"Miller","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006454-198704000-00004","article-title":"Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children","volume":"6","author":"Pichichero","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.01.018_b0115","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.vaccine.2015.06.036","article-title":"Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis vaccines (Td-IPV or DT-IPV) and immune responses to a booster dose of DTaP-IPV","volume":"33","author":"Gajdos","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0120","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/j.vaccine.2015.06.105","volume":"33","author":"John","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/hv.6.7.11760","article-title":"Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix IPV)","volume":"6","author":"Knuf","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.01.018_b0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.vaccine.2004.06.012","article-title":"Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model","volume":"23","author":"Cheuvart","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0135","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.vaccine.2016.06.051","article-title":"The predicted persistence and kinetics of antibody decline 9 years after pre-school booster vaccination in UK children","volume":"34","author":"Voysey","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.018_b0145","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.vaccine.2012.02.013","article-title":"Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine","volume":"30","author":"Tomovici","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0150","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2014.09.017","article-title":"Vaccine safety implications of Ontario, Canada's switch from DTaP-IPV to Tdap-IPV for the pre-school booster","volume":"32","author":"Klar","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2004.06.044","article-title":"Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4\u20136 years of age\u2013a comparison of two vaccines with different amounts of diphtheria toxoid","volume":"23","author":"Thierry-Carstensen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0160","unstructured":"Government of Canada. Canada's Provincial and Territorial Routine (and Catch-up) Vaccination Routine Schedule Programs for Infants and Children, 2019 [Accessed 3 December 2019]. https:\/\/www.canada.ca\/en\/public-health\/services\/provincial-territorial-immunization-information\/provincial-territorial-routine-vaccination-programs-infants-children.html."},{"key":"10.1016\/j.vaccine.2020.01.018_b0165","unstructured":"Government of Chile Ministry of Health. Calendarios de Vacunaci\u00f3n, 2019 [Accessed 3 December 2019]. https:\/\/vacunas.minsal.cl\/informacion-a-la-comunidad\/calendario-de-vacunacion\/."},{"key":"10.1016\/j.vaccine.2020.01.018_b0170","unstructured":"Statens Serum Institute. Det danske b\u00f8rnevaccinationsprogram, 2019 [Accessed 3 December 2019]. https:\/\/www.ssi.dk\/vaccinationer\/boernevaccination."},{"key":"10.1016\/j.vaccine.2020.01.018_b0175","unstructured":"Directorate of Health Chief Epidemiologist of Iceland. National Childhood Vaccination Programme in Iceland as of September 2015, 2015 [Accessed 3 December 2019]. https:\/\/www.landlaeknir.is\/servlet\/file\/store93\/item27472\/Almennar_bolusetningar_barna_eftir_september_2015_ENSKA.pdf."},{"key":"10.1016\/j.vaccine.2020.01.018_b0180","unstructured":"Ireland Health Service Executive National Immunisation Office. School Programme 2019\/2020: 4 in 1 and MMR, 2019 [Accessed 3 December 2019]. https:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/othervaccines\/4n1mmr\/."},{"key":"10.1016\/j.vaccine.2020.01.018_b0185","unstructured":"State of Israel Ministry of Health. Vaccines for Babies and Children; 2019 [Accessed 3 December 2019]. https:\/\/www.health.gov.il\/English\/Topics\/Pregnancy\/Vaccination_of_infants\/Pages\/default.aspx."},{"key":"10.1016\/j.vaccine.2020.01.018_b0190","unstructured":"Robert Koch Institute. Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute \u2013 2017\/2018, 2017 [Accessed 3 December 2019]. https:\/\/www.rki.de\/EN\/Content\/infections\/Vaccination\/recommandations\/recommendations_node.html."},{"key":"10.1016\/j.vaccine.2020.01.018_b0195","unstructured":"The Government of the Grand Duchy of Luxembourg. Calendrier des vaccinations, 2019 [Accessed 3 December 2019]. http:\/\/sante.public.lu\/fr\/prevention\/vaccination\/calendrier-vaccinal\/index.html."},{"key":"10.1016\/j.vaccine.2020.01.018_b0200","unstructured":"National Institute for Public Health and the Environment (RIVM). The National Immunisation Programme in the NetherlandsSurveillance and developments in 2017-2018, 2018 [Accessed 3 December 2019]. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2018-0124.pdf."},{"key":"10.1016\/j.vaccine.2020.01.018_b0205","unstructured":"Department of Health Republic of South Africa. Expanded Programme of Immunisation Revised Childhood Immunisation Schedule from December 2015, [Accessed 3 December 2019]. 2016. https:\/\/www.westerncape.gov.za\/assets\/departments\/health\/2016_schedule.pdf."},{"key":"10.1016\/j.vaccine.2020.01.018_b0210","unstructured":"Public Health England. Pertussis: the Green Book, chapter 24 (April 2016), [Accessed 3 December 2019]. https:\/\/www.gov.uk\/government\/publications\/pertussis-the-green-book-chapter-24."},{"key":"10.1016\/j.vaccine.2020.01.018_b0215","unstructured":"Italy Ministry of Health. Il calendario vaccinale del Piano Nazionale di Prevenzione Vaccinale 2017-2019, 2017 [Accessed 3 December 2019]. http:\/\/www.salute.gov.it\/imgs\/C_17_pagineAree_4829_listaFile_itemName_0_file.pdf."},{"key":"10.1016\/j.vaccine.2020.01.018_b0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268899004161","article-title":"The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network","volume":"125","author":"Edmunds","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.01.018_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148605","article-title":"Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study","volume":"11","author":"Swart","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.01.018_b0230","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1469-0691.2006.01504.x","article-title":"Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel","volume":"12","author":"Valinsky","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2020.01.018_b0235","unstructured":"European Centre for Disease Control and Prevention. Rapid risk assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU\/EEA (1st update, 2 February 2016), 2016 [Accessed 3 December 2019]. https:\/\/ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-shortage-acellular-pertussis-containing-vaccines-and-0."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.01.018_b0240","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/315534","article-title":"Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned","volume":"181","author":"Dittmann","year":"2000","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.01.018_b0245","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1086\/315570","article-title":"Implications of the diphtheria epidemic in the Former Soviet Union for immunization programs","volume":"181","author":"Galazka","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.018_b0250","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(98)03488-6","article-title":"Risk of diphtheria among schoolchildren in the Russian Federation in relation to time since last vaccination","volume":"353","author":"Vitek","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.vaccine.2020.01.018_b0255","unstructured":"World Health Organization. Vaccine and immunization quality and safety, [Accessed 3 December 2019]. https:\/\/www.who.int\/immunization\/quality_safety\/en\/."},{"key":"10.1016\/j.vaccine.2020.01.018_b0260","unstructured":"World Health Organization (WHO). WHO Prequalified Vaccines: Influenza, seasonal (Trivalent) GC FLU inj, [Accessed 3 December 2019]. https:\/\/extranet.who.int\/gavi\/PQ_Web\/PreviewVaccine.aspx?nav=0&ID=233."},{"key":"10.1016\/j.vaccine.2020.01.018_b0265","first-page":"461","article-title":"Vaccines against influenza WHO position paper - November 2012","volume":"87","author":"World Health Organization (WHO)","year":"2012","journal-title":"Wkly Epidemiol Rec."},{"key":"10.1016\/j.vaccine.2020.01.018_b0270","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/S0264-410X(99)00065-1","article-title":"Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age","volume":"17","author":"Dagan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0275","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1016\/S0264-410X(03)00496-1","article-title":"Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4\u20136 year-old children primed with four doses of whole-cell pertussis vaccine","volume":"21","author":"Kosuwon","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0280","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.vaccine.2004.04.027","article-title":"Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children","volume":"22","author":"Collins","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jadohealth.2005.08.009","article-title":"Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents","volume":"37","author":"Huang","year":"2005","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2020.01.018_b0290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4161\/hv.4.1.4935","article-title":"Booster vaccination at 6\u20138 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine","volume":"4","author":"Lin","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.01.018_b0295","doi-asserted-by":"crossref","DOI":"10.4161\/hv.6.3.10503","article-title":"Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix)","volume":"6","author":"Zhu","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.01.018_b0300","series-title":"Technical Report. Stockholm: Swedish Institute for Infectious Disease Control","article-title":"Antibody responses and clinical reactions to booster doses of TdcP + IPV, TdcP \u2212 IPV or DT + IPV at 5\u00bd years of age after primary immunisation with DTcP (DTPa5) at 3, 5 and 12 months of age in Pertussis Vaccine Trial II","author":"Gustafsson","year":"2000"},{"key":"10.1016\/j.vaccine.2020.01.018_b0305","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/01.inf.0000190028.96152.46","article-title":"A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial","volume":"24","author":"Scheifele","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.vaccine.2020.01.018_b0310","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2006.09.053","volume":"25","author":"Langley","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.018_b0315","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4161\/hv.18650","volume":"8","author":"Ferrera","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.01.018_b0320","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00431-006-0403-x","article-title":"Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine","volume":"166","author":"Sanger","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2020.01.018_b0325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4161\/hv.7.5.14982","article-title":"Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS\u00ae) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio\u00ae) given as a booster dose at 6 years of age","volume":"7","author":"Gajdos","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.01.018_b0330","unstructured":"European Centre for Disease Control and Prevention. Evaluation and assessment of serological immunity methods and external quality assessment scheme of diphtheria, 2014 [Accessed 3 December 2019]. ."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:49Z","timestamp":1759401769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":66,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20300335"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of tetanus-diphtheria (Td) vaccine in children 4\u20137\u00a0years of age: World Health Organization consultation of experts","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 World Health Organization; licensee Elsevier.","name":"copyright","label":"Copyright"}]}}